StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by LittleGuy2on May 02, 2020 3:42pm

169 Views

Post# 30979774

RE:Learning more each day. ELISA

Hi Nails,
Thermo Fischer did receive FDA emergency use authorization on March 13th for its "TaqPath Covid-19 Combo Kit" that runs on a Thermo Fischer "Applied Biosystems 7500" instrument in CLIA approved labs. So, I guess the questions are does the SZLS lab have this instrument and is there an available supply of the assay reagent.

Bullboard Posts

Debt-free cannabis company set for next stage of growth